The PROPHETIC trial involves patients with Stage IV non-small cell lung cancer, small cell lung cancer or malignant melanoma, and seeks to determine who will or will not respond to various forms of immunotherapies.
Florida Cancer Specialists & Research Institute Participating in Global Clinical Trial Analyzing Patient Responsiveness to Immunotherapy Treatment
May 02, 2022 08:00 ET | Florida Cancer Specialists & Research Institute
Fort Myers, Florida, May 02, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute medical oncologist Ernesto Bustinza-Linares, MD is serving as a Principal Investigator in a...